Panagora Asset Management Inc Bei Gene, Ltd. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Panagora Asset Management Inc holds 13,454 shares of BGNE stock, worth $2.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,454

Previous 1,425 844.14%

Holding current value

$2.56 Million

Previous $203,000 1387.68%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$143.93 - $224.51 $1.73 Million - $2.7 Million	12,029 Added 844.14%	13,454 $3.02 Million
Q4 2022 Feb 13, 2023	SELL	$125.51 - $229.3 $216,253 - $395,083	-1,723 Reduced 54.73%	1,425 $313,000
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $59,441 - $91,210	451 Added 16.72%	3,148 $424,000
Q2 2022 Aug 15, 2022	SELL	$121.11 - $216.05 $302,532 - $539,692	-2,498 Reduced 48.08%	2,697 $437,000
Q1 2022 May 12, 2022	BUY	$146.52 - $269.56 $26,813 - $49,329	183 Added 3.65%	5,195 $980,000
Q3 2021 Nov 10, 2021	BUY	$249.6 - $403.14 $16,972 - $27,413	68 Added 1.38%	5,012 $1.82 Million
Q2 2021 Aug 11, 2021	BUY	$292.75 - $367.01 $108,317 - $135,793	370 Added 8.09%	4,944 $1.7 Million
Q1 2021 May 12, 2021	BUY	$260.64 - $382.12 $666,195 - $976,698	2,556 Added 126.66%	4,574 $1.59 Million
Q4 2020 Feb 10, 2021	SELL	$221.31 - $316.61 $1.22 Million - $1.75 Million	-5,521 Reduced 73.23%	2,018 $521,000
Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $1.42 Million - $2.16 Million	-7,528 Reduced 49.96%	7,539 $2.16 Million
Q2 2020 Aug 12, 2020	BUY	$123.9 - $195.41 $275,677 - $434,787	2,225 Added 17.33%	15,067 $2.84 Million
Q1 2020 May 14, 2020	SELL	$121.84 - $173.19 $784,040 - $1.11 Million	-6,435 Reduced 33.38%	12,842 $1.58 Million
Q2 2019 Aug 09, 2019	BUY	$113.99 - $146.86 $428,830 - $552,487	3,762 Added 24.25%	19,277 $2.39 Million
Q1 2019 May 15, 2019	BUY	$122.82 - $151.83 $1.91 Million - $2.36 Million	15,515 New	15,515 $2.05 Million

Others Institutions Holding BGNE

# of Institutions

250

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Bei Gene, Ltd. Transaction History